Mikko Turunen | Chief Scientific Officer
RNatives
Mikko Turunen, PhD, Founder of RNatives and Adjunct Professor of Molecular Medicine at the University of Eastern Finland, has +28 years of experience in the development of gene therapies. Throughout his career, his research focus has been non-coding RNAs in transcriptional gene regulation. He was the first to show transcriptional gene activation by small RNAs in vivo (2009).
Appearances:
Festival of Biologics Day 2 @ 17:50
Use of AI-assisted Discovery Platform for Transcriptional Gene Regulation by Nuclear Small RNAs
- Small RNAs regulate transcription by epigenetic mechanism in cell nucleus by targeting promoter associated RNAs.
- Interactions of nuclear RNAs is very complex and RNatives has used AI/ML to pinpoint the most effective RNAs
- RNatives is developing therapeutic small RNAs for various indications, including Ophthalmology, Metabolic disease, Oncology and Cardiovascular disease
last published: 22/Aug/25 15:25 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events